The pharmaceutical industry is undergoing a significant transformation driven by artificial intelligence (AI). This revolution is not just about improving processes but reshaping disease treatment and care delivery. Early adopters of AI in this sector are experiencing substantial gains,
Clinical trials have long been the cornerstone of medical innovation, providing the rigorous testing needed to bring new treatments and medications to market. However, traditional clinical trials are often seen as time-consuming, expensive, and inaccessible. In this context, the emergence of
The rise of digital health solutions is changing the dynamics of healthcare delivery, bringing technological innovation to aid patient diagnosis, treatment, and monitoring. This rapid growth, as highlighted by the IQVIA Institute for Human Data Science, sees digital health products reaching an
The healthcare landscape in the Balkan region is undergoing a significant transformation, driven by the adoption of Electronic Health Records (EHR), the integration of artificial intelligence (AI), and the push for interoperability with European Union (EU) standards. This article delves into the
Historically, anaplastic thyroid cancer (ATC) has been one of the most aggressive and challenging forms of cancer to treat, with traditional methods often resulting in poor survival rates. Treatment has remained a significant struggle, causing dismay for both patients and healthcare providers.
The Institute of Cancer Research (ICR) in London is teaming up with Healx, a biotech firm known for its expertise in artificial intelligence (AI) and machine learning, to develop potential new therapies for diffuse intrinsic pontine glioma (DIPG), a rare and currently untreatable form of childhood
